ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
ASTRAZENECA PLC ADRhedged
53.28
0.0000
成交量:
- -
成交額:
- -
市值:
159.83萬
市盈率:
- -
高:
53.28
開:
53.28
低:
53.28
收:
53.28
52周最高:
56.90
52周最低:
44.36
股本:
3.00萬
流通股本:
1.00萬
量比:
- -
換手率:
- -
股息:
0.58
股息率:
1.08%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
阿斯利康長效C5補體抑制劑偉立瑞獲批上市
南方财经网
·
08/20
偉立瑞®在華獲批用於治療成人和1月齡及以上兒童陣發性睡眠性血紅蛋白尿症(PNH)患者
美通社
·
08/20
阿斯利康(AZN.US)瑞利珠單抗第3項適應症在中國獲批上市
智通财经
·
08/20
美股生物醫藥概念持續衝高,Moderna升逾130%,默沙東升逾11%
老虎资讯综合
·
08/19
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/AZNH"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AZNH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","market":"US","secType":"STK","nameCN":"ASTRAZENECA PLC ADRhedged","latestPrice":53.2774,"timestamp":1787601600000,"preClose":53.2774,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":10000,"shares":30000,"eps":0,"marketStatus":"停牌","change":0,"latestTime":"08-24 16:00:00 EDT","open":53.2774,"high":53.2774,"low":53.2774,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"exchange":"NYSE","adjPreClose":53.2774,"dividendRate":0.010836,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AZNH\",,,,,undefined,":{"symbol":"AZNH","floatShares":10000,"roa":"--","roe":"--","lyrEps":0,"shares":30000,"dividePrice":0.57729,"high":53.2774,"amplitude":0,"preClose":53.2774,"low":53.2774,"week52Low":44.36,"pbRate":"--","week52High":56.8955,"institutionHeld":0,"latestPrice":53.2774,"eps":0,"divideRate":0.010836,"volume":0,"delay":0,"ttmEps":0,"open":53.2774,"prevYearClose":54.226,"prevWeekClose":53.2774,"prevMonthClose":53.2774,"prevQuarterClose":53.2774,"fiveDayClose":53.2774,"twentyDayClose":53.2774,"sixtyDayClose":53.2774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AZNH\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"AZNH","amount":0.57729,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2024-12-16","symbol":"AZNH","amount":2.71402,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-16","defaultRemindTime":1734359400000,"name":"ASTRAZENECA PLC ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-23","payableDate":"2024-12-16","currency":"USD","dateTimestamp":1734325200000,"payDate":"2024-12-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AZNH\",market:\"US\",,,undefined,":[{"executeDate":"2024-12-16","recordDate":"2024-12-16","paymentDate":"2024-12-23","value":2.71402,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.57729,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AZNH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AZNH\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660286748","title":"阿斯利康長效C5補體抑制劑偉立瑞獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2660286748","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660286748?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 18:58","pubTimestamp":1787223480,"startTime":"0","endTime":"0","summary":"南方财经8月20日电,记者获悉,阿斯利康罕见病业务旗下的长效C5补体抑制剂伟立瑞?(英文商品名:Ultomiris?,通用名:瑞利珠单抗注射液),已获得中国国家药品监督管理局(NMPA)批准,用于成人和1月龄及以上儿童阵发性睡眠性血红蛋白尿症(PNH)患者的治疗。PNH是一种慢性、进行性且危及生命的血液系统罕见疾病。该疾病好发于青壮年,77%的PNH患者在20-40岁发病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608203847950261.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608203847950261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0708994859.HKD","LU2456880835.USD","BK4007","AZN","LU2237443382.USD","LU0432979614.USD","IE00B3T34201.USD","LU1267930573.SGD","LU0109394709.USD","LU0889565916.HKD","BK4588","LU2236285917.USD","BK4568","LU2237443622.USD","LU0029864427.USD","LU2237443549.SGD","LU2089984988.USD","LU2237443465.HKD","LU1829250122.USD","LU2417539215.USD","BK4585","LU2237443978.SGD","LU2237443895.HKD","LU0320765992.SGD","LU0058720904.USD","AZNH","LU0289739699.SGD","LU2462157665.USD","LU0310800379.SGD","LU0128525929.USD","IPOS","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660284301","title":"偉立瑞®在華獲批用於治療成人和1月齡及以上兒童陣發性睡眠性血紅蛋白尿症(PNH)患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2660284301","media":"美通社","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660284301?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 18:58","pubTimestamp":1787223480,"startTime":"0","endTime":"0","summary":"此次瑞利珠单抗获批,为成人及儿童PNH患者带来了兼具长效性、稳定性和便利性的治疗选择,可实现快速、完全且持续的终末补体抑制。目前,瑞利珠单抗在中国、美国、欧盟、日本等国家和地区获批用于治疗特定的阵发性睡眠性血红蛋白尿症的成人及儿童患者,并在全球多个国家和地区获批多项适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5030457_ZH30457_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5030457_ZH30457_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2237443465.HKD","LU2468319806.SGD","LU2089984988.USD","LU2236285917.USD","BK4007","LU1267930573.SGD","LU0320765992.SGD","BK4588","LU2462157665.USD","LU2237443549.SGD","LU1829250122.USD","LU2456880835.USD","LU0432979614.USD","LU2237443382.USD","LU2237443622.USD","LU0058720904.USD","LU0310800379.SGD","LU2237443978.SGD","LU0109394709.USD","BK4568","LU2417539215.USD","LU0889565916.HKD","IE00B3T34201.USD","LU0708994859.HKD","LU0289739699.SGD","LU0128525929.USD","AZN","LU2237443895.HKD","LU0029864427.USD","AZNH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660407362","title":"阿斯利康(AZN.US)瑞利珠單抗第3項適應症在中國獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2660407362","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660407362?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 16:50","pubTimestamp":1787215836,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,8月20日,国家药品监督管理局官网显示,阿斯利康“瑞利珠单抗”国内再获批一项新适应症,用于治疗阵发性睡眠性血红蛋白尿症。瑞利珠单抗于2025年4月首次获批进入中国,用于治疗抗AChR抗体阳性的成人全身型重症肌无力,后又拓展适应症至NMOSD。瑞利珠单抗此次新适应症获批,成为国内第7款、进口第4款PNH治疗药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482601.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0058720904.USD","LU1829250122.USD","LU2237443978.SGD","LU0128525929.USD","LU0109394709.USD","LU2237443549.SGD","LU0889565916.HKD","LU2236285917.USD","IE00B3T34201.USD","LU2237443622.USD","LU0432979614.USD","LU0708994859.HKD","LU0029864427.USD","IPOS","BK4007","AZNH","LU0289739699.SGD","LU0320765992.SGD","AZN","LU2237443465.HKD","LU2468319806.SGD","LU2417539215.USD","BK4585","LU2456880835.USD","LU2089984988.USD","LU0310800379.SGD","LU1267930573.SGD","BK4568","LU2237443382.USD","LU2237443895.HKD","BK4588","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156346136","title":"美股生物醫藥概念持續衝高,Moderna升逾130%,默沙東升逾11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156346136","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156346136?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 22:06","pubTimestamp":1787148392,"startTime":"0","endTime":"0","summary":"8月19日,美股生物医药概念持续冲高,$Moderna(MRNA)$涨幅扩大至130%,$默沙东(MRK)$涨超11%,$礼来(LLY)$涨超5%,$辉瑞(PFE)$、$诺和诺德(NVO)$、$阿斯利康(AZN)$等涨约3%。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772840.SGD","MHIP","LU1162221912.USD","LU0943347566.SGD","LU1804176565.USD","LU2750360641.GBP","SG9999017495.SGD","BK7104","LU0109391861.USD","LU2089283258.USD","LU2271345857.HKD","LU0316494557.USD","LU0648001328.SGD","IE0005OL40V9.USD","XBI","IE00B1XK9C88.USD","LU0323591593.USD","LU0471298777.SGD","IE00BJJMRX11.SGD","LU0823434583.USD","GDOC","LU1116320901.HKD","IE00BKDWB100.SGD","LU0306806265.USD","ILDR","SG9999015978.USD","LU0198837287.USD","LU2125909593.SGD","SG9999014542.SGD","LU0965509283.SGD","LU2324357040.USD","LU0432979614.USD","BK4592","LU2023250843.SGD","LU0820561909.HKD","LU1623119135.USD","LU0109394709.USD","LU0203347892.USD","LU0823434740.USD","LU0823416689.USD","SG9999014898.SGD","LU0154236417.USD","IE00BFTCPJ56.SGD","LU0265550359.USD","LU1585245621.USD","LU0708995401.HKD","LU0256863902.USD","TRUH","TMED","SG9999013999.USD","LU1066051811.HKD","IE00B4JS1V06.HKD","LU0256863811.USD","SG9999014914.USD","LU2896262040.SGD","LU2491050154.USD","LU0417517546.SGD","IE00BJJMRZ35.SGD","LU0070302665.USD","LU2471134952.CNY","SG9999001440.SGD","SG9999011175.SGD","LU2168564222.USD","IE00B3T34201.USD","BK4585","SG9999001176.SGD","LU1934455277.USD","LU1720051017.SGD","PPH","IE00B7KXQ091.USD","MRNX","LU0130102774.USD","LU0980610538.SGD","SGXZ81514606.USD","LU0353189680.USD","LU0234572021.USD","LU2552382132.HKD","IE00BKVL7J92.USD","SG9999015986.USD","LU0097036916.USD","CURE","SG9999002232.USD","AGNG","LU2471134796.USD","LU0889565916.HKD","LU1894683348.USD","LU0158827781.USD","LU2456880835.USD","OZEM","LU0477156953.USD","LU0942090050.USD","LU0820562030.AUD","SG9999014880.SGD","SG9999014567.USD","LU2237443622.USD","IE00BN29S564.USD","IE00BJJMRY28.SGD","LU0208291251.USD","IE00BLSP4239.USD","LU0170899867.USD","BK4599","LU2265009873.SGD","FTXH","BK4551","LU0158827948.USD","LU2491049909.HKD","LU1829250122.USD","LU0265550946.USD","BK4516","IE0004445015.USD","LU2023250504.SGD","LU0882574139.USD","IE0002141913.USD","LU2237443382.USD","LU1093756168.USD","LU2746668974.SGD","LU0882574055.USD","SGXZ51526630.SGD","IE00B4R5TH58.HKD","LU0114720955.EUR","LU1267930573.SGD","LU2112291526.USD","LU0203202063.USD","LU2468319806.SGD","LU0672654240.SGD","IE00BLSP4452.SGD","LU0354030511.USD","LU0321505439.SGD","LU0124676726.USD","LU1883839398.USD","LU2237443978.SGD","LU0320765059.SGD","LU0203201768.USD","BK4550","LU2237438978.USD","LU2602419157.SGD","LU0456855351.SGD","IE00BFSS8Q28.SGD","BK4568","LU0238689110.USD","LU2028103732.USD","LU0965508806.USD","LU2596442595.SGD","LU1037948897.HKD","LU2087625088.SGD","IE0009355771.USD","LU1548497426.USD","LU2361044949.HKD","MEDI","LU2746668461.USD","LU1979441026.SGD","LU0868494708.USD","LU1035773651.USD","LU2750360997.AUD","BK4007","IE00BWXC8680.SGD","GB00BDT5M118.USD","BK4532","IE00B19Z3581.USD","BMED","RXL","LU1868836591.USD","LU2237443895.HKD","LU0689472784.USD","BK4139","LU1037948541.HKD","XLV","LU0466842654.USD","LU0128525929.USD","LU1430594728.SGD","LU0320765489.SGD","LU0354030438.USD","LU2471134879.HKD","LU2471134523.USD","LU0006306889.USD","IE00B19Z3B42.SGD","LU0225283273.USD","LU2111349929.HKD","LU2433249047.HKD","LU0133085943.USD","LU1291159041.SGD","LU2360106947.USD","LU1868836757.USD","LU1551013425.SGD","LU0345770993.USD","SGXZ57979304.SGD","LU1629891620.HKD","LU1691799644.USD","LU2106854487.HKD","LU1720051108.HKD","LU1868836914.USD","LU2089284900.SGD","AZNH","LU0096364046.USD","BK7095","LU0985320562.USD","SGXZ31699556.SGD","PAWZ","BGIA","IYH","LU0174119429.USD","IE00BFSS7M15.SGD","LU2168564065.EUR","LU1934455863.HKD","LU2168563687.JPY","LU2461242641.AUD","BK4581","IE00B775H168.HKD","LU1145028129.USD","LU2756315318.SGD","LU0385154629.USD","LU0306807586.USD","LU2023250330.USD","LU1551013342.USD","SG9999018865.SGD","LU2089984988.USD","CANC","LU1280957306.USD","LU2361045086.USD","IE00BJT1NW94.SGD","LU0683600562.USD","LU1066053197.SGD","LU2491050071.SGD","LU0786609619.USD","LU1983299246.USD","LU0130517989.USD","LU1868837136.USD","LU2361044865.SGD","LU0266013472.USD","LU0708994859.HKD","LU1267930730.SGD","LU1814569148.SGD","LU1323610961.USD","LGHT","LU0225771236.USD","LU2211815571.USD","LU2552382215.SGD","MRNY","LU0203345920.USD","IE00BBT3K403.USD","SG9999014575.USD","IE00BJLML261.HKD","LU2168564495.EUR","VHT","LU0211331839.USD","LU0106261372.USD","LU0321505868.SGD","IE00B1BXHZ80.USD","SG9999014559.SGD","LU2213496289.HKD","LU0310800379.SGD","LU2023251221.USD","LU1232071149.USD","LU1941712264.USD","LU2462591350.SGD","LU1127390331.HKD","LU2168564149.EUR","IE00BN8TJ469.HKD","LU1066051225.USD","MRK","LU2125154935.USD","LU2417539215.USD","BK4559","JDOC","LU1934455194.USD","IE00B2B36J28.USD","BK4588","LU0320765992.SGD","GNOM","LU0689626769.HKD","IDNA","SG9999002224.SGD","BK4533","LU1974910355.USD","LU0289739699.SGD","IXJ","LU0965509010.AUD","LU2108987350.USD","SG9999014906.USD","LU0320765646.SGD","MEDX","LU2125909247.SGD","THNR","LU0868494617.USD","SG9999015952.SGD","SG9999003800.SGD","HRTS","LU2236285917.USD","LU0861579265.USD","SG9999015341.SGD","LU0122379950.USD","LU2756315664.SGD","SG9999015358.SGD","FHLC","LU2357627491.SGD","LU1366192091.USD","SG9999018857.SGD","BK4534","LU1023059063.AUD","LU0058720904.USD","BK4501","LU2360032135.SGD","LU0965509101.SGD","LU1988902786.USD","LU0353189763.USD","BK4548","LU0471298694.HKD","LU1093756325.SGD","IE000M9KFDE8.USD","LU2063271972.USD","LU1929549753.HKD","IE00BK4W5M84.HKD","LU0094547139.USD","LU0098860793.USD","MRNA","LU1712237335.SGD","LU1064131342.USD","LU0079474960.USD","IE00BSNM7G36.USD","LU2125154778.USD","LU0345770308.USD","IE00BKPKM429.USD","IE0004445239.USD","LU1201861249.SGD","IE0002270589.USD","LU1894683264.USD","LU0985481810.HKD","LU1069347547.HKD","LU1868837300.USD","LU2264538146.SGD","LU2237443549.SGD","LU1571399168.USD","LU0859254822.USD","LU1035775433.USD","LU2357305700.SGD","LU2462157665.USD","IHE","LU0640476718.USD","LU0964807845.USD","LU1989772923.USD","LU1699723380.USD","LU1941712348.USD","WDNA","LU1989771016.USD","IE00BZ1G4Q59.USD","LU1917777945.USD","LU0061475181.USD","LU1923622614.USD","LU1066051498.USD","SG9999001176.USD","IE0001KFT4U8.USD","PJP","161726","LU1057294990.SGD","LU0029864427.USD","LU1069344957.HKD","IE00BK4W5L77.USD","LU2552382058.USD","LU0787776722.HKD","LU0225284248.USD","LU2237443465.HKD","SG9999015945.SGD","SGXZ99366536.SGD","LU0210536198.USD","LU1116320737.USD","LU0820561818.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":37,"pageCount":1,"totalSize":148,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AZNH\",params:#limit:6,delay:false,,,undefined,":[]}}